Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
The Journal of Biological Chemistry|January 27, 2005
Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegenerationSasha F Levy, Adria C Leboeuf, Michelle R Massie, et al.Biochemistry|October 6, 2015
Effects of eribulin on microtubule binding and dynamic instability are strengthened in the absence of the βIII tubulin isotypeLeslie Wilson, Manu Lopus, Herbert P Miller, et al.The Journal of Biological Chemistry|September 19, 2002
Intrinsically slow dynamic instability of HeLa cell microtubules in vitroCori N Newton, Jennifer G DeLuca, Richard H Himes, et al.Journal of Alzheimer'S Disease : JAD|January 12, 2010
The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubulesMythili Yenjerla, Nichole E LaPointe, Manu Lopus, et al.Biophysical Journal|May 27, 2008
Microtubule assembly of isotypically purified tubulin and its mixturesVahid Rezania, Olga Azarenko, Mary Ann Jordan, et al.Biochemistry|December 25, 2009
Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instabilityJennifer A Smith, Leslie Wilson, Olga Azarenko, et al.Molecular Cancer Therapeutics|October 13, 2010
Maytansinoid-antibody conjugates induce mitotic arrest by suppressing microtubule dynamic instabilityEmin Oroudjev, Manu Lopus, Leslie Wilson, et al.Molecular Cancer Therapeutics|July 16, 2005
The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growthMary Ann Jordan, Kathryn Kamath, Tapas Manna, et al.Cancer Research|April 19, 2007
Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylateAnasuya Ray, Tatiana Okouneva, Tapas Manna, et al.Cancer Research|August 5, 2016
Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer DrugsJennifer A Smith, Barbara S Slusher, Krystyna M Wozniak, et al.Pageof 5